XML 14 R4.htm IDEA: XBRL DOCUMENT v3.22.2
CONDENSED CONSOLIDATED BALANCE SHEET - UNAUDITED - USD ($)
$ in Millions
Jun. 30, 2022
Dec. 31, 2021
Current assets    
Cash and cash equivalents ($557 and $630 related to VIEs) $ 2,074 $ 2,209
Marketable securities ($82 and $90 related to VIEs) 120 127
Accounts receivable, net ($175 and $173 related to VIEs) 993 1,171
Contract assets ($228 and $223 related to VIEs) 1,047 1,066
Other current assets ($32 and $28 related to VIEs) 408 608
Total current assets 4,642 5,181
Noncurrent assets    
Property, plant and equipment, net ($42 and $46 related to VIEs) 478 456
Investments 560 517
Deferred taxes 58 51
Deferred compensation trusts 237 330
Goodwill 248 249
Other assets ($43 and $45 related to VIEs) 302 305
Total noncurrent assets 1,883 1,908
Total assets 6,525 7,089
Current liabilities    
Accounts payable ($263 and $261 related to VIEs) 1,020 1,220
Short-term debt 181 18
Contract liabilities ($268 and $351 related to VIEs) 719 945
Accrued salaries, wages and benefits ($21 and $27 related to VIEs) 564 629
Other accrued liabilities ($33 related to VIEs in both periods) 642 802
Total current liabilities 3,126 3,614
Long-term debt 980 1,174
Deferred taxes 62 67
Other noncurrent liabilities ($14 and $13 related to VIEs) 556 667
Contingencies and commitments
Temporary APIC 107 0
Shareholders’ equity    
Preferred stock — authorized 20,000,000 shares ($0.01 par value); issued and outstanding — 600,000 shares in 2022 and 2021 0 0
Common stock — authorized 375,000,000 shares ($0.01 par value); issued and outstanding — 142,082,682 and 141,434,771 shares in 2022 and 2021, respectively 1 1
APIC 983 967
AOCI (355) (366)
Retained earnings 885 791
Total shareholders’ equity 1,514 1,393
NCI 180 174
Total equity 1,694 1,567
Total liabilities and equity $ 6,525 $ 7,089